Objectives: To describe and compare antibiotic prescribing patterns for primary care patients with respiratory tract infections (RTIs) in four South American countries.
Introduction
The global action plan on antimicrobial resistance 1 recommends promotion of the proper use of antibiotics as one of the key strategies to curb the development of resistant strains.
South American countries and other low-and middle-income countries have social, health system and clinical factors that might increase resistance to antibiotics. 2 Surveillance systems for antibiotic resistance at hospital 3, 4 and community 5 -7 levels in South America have reported a growing prevalence of resistant strains for the most common pathogens involved in bacterial respiratory tract infections (RTIs), namely Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis.
Overuse of antibiotics in primary care has been linked to development of resistant strains. 8 RTIs are one of the most common causes for prescribing antibiotics in primary care worldwide, 9, 10 and marked variation has been reported in the management of RTIs across countries. 11 -13 Previous research has reported that there are factors at social, 14, 15 general practitioner (GP) 13, 16, 17 and patient levels 18 -20 associated with the decision to prescribe antibiotics. The complexity of these multilevel interactions causes variation in the use of antibiotics within and across countries, impacting on the implementation and subsequent effectiveness of common interventions aimed at increasing the appropriate use of antibiotics. There is scarce information about antibiotic prescribing for patients with suspected RTI attending primary care in South America. Other studies with data from South America have contributed to the understanding of antibiotic prescribing in this part of the world; however, their findings cannot be fully used to understand the mechanism of variation and antibiotic prescribing within the primary care context. 21 For example, a report from the nationwide programme REMEDIAR 23 in Argentina showed information about the type of diagnosis and the types of antibiotic used in primary care; however, no information is available at the patient level to understand how patient characteristics affect the decision to prescribe antibiotics across regions in Argentina.
Sosa and Travers 24 in a report from 2002 described prescribing of antibiotics by secondary care clinicians. The indications to prescribe antibiotics and the type of patients differ between primary and secondary care.
Finally, two studies about the retail sale of antibiotics 21, 22 demonstrated an increase in the use of antibiotics in South America; however, lack of clinical information limits the possibility of linking the increase in sales with an increase in prescriptions and the number of patients suffering from bacterial RTI. Overall, the above shows the need to expand our knowledge of the use of antibiotics in patients with suspected RTI in South America if we are to design and implement long-lasting and effective interventions, which may contribute to the global goal of limiting the development of antibiotic-resistant strains.
Therefore, this study describes and compares antibiotic prescribing in patients with suspected RTI seeking care at the primary care level in four countries in South America. 
Methods

Ethics
Design and settings
This was a prospective observational study carried out in four countries (Argentina, Bolivia, Paraguay and Uruguay) as part of the quality improvement project Health Alliance for Prudent Prescribing, Yield and Use of Antimicrobial Drugs in the Treatment of Respiratory Tract Infections in South America (HAPPY AUDIT-II; www.red-atencionprimaria.info).
Recruitment of patients
GPs from each country included all patients without age restriction with suspected RTI during the winter of 2014 (June-August). Patients were included only once and those who had started antibiotics were excluded. These broad criteria allowed the inclusion of a wide range of patients attending primary care facilities across the different countries.
Data collection
A background questionnaire was completed by each GP. The questionnaire was divided into: (i) personal characteristics, (ii) organization of service, and (iii) risk attitudes (Appendix 1, available as Supplementary data at JAC Online), in accordance with previous work assessing predictors of antibiotic use at the GP level. 25, 26 Furthermore, during each consultation GPs completed a questionnaire about the clinical characteristics of the patient and the decisions regarding diagnosis and treatment (Appendix 2).
Sample size
Due to the observational design and lack of information about the level of clustering, we conservatively calculated the sample size based on an estimate of a 50% probability of prescribing antibiotics. Thus, the requested sample size was 380 patients per country to give a 95% CI of 44%-56% for detecting the 50% probability within each country.
Data management and analysis
All questionnaires were double-entered and checked for errors in a central database. Descriptive statistics were calculated by using medians (IQRs) and proportions as appropriate.
Antibiotic prescribing was assessed by using a mixed-effect logistic model fitted to the data from the questionnaires, with patients nested within clinicians. The dependent variable was the binary variable 'prescribing of antibiotics' with a random intercept at the GP level. The variable 'country' was included as a fixed effect, and then all countries were compared with the overall mean. Potential confounders were assessed in an adjusted univariate model and those significant at the 5% level were included in the final model.
The descriptive and statistical analysis was performed in the R programming language and environment (version 3.0.2) using the lme4, nlme packages. 27, 28 Observations with one or more missing values were omitted from the analysis.
Results
In total, 171 GPs participated in the study, which included 11446 patients. GP and patient characteristics are available as Supplementary data at JAC Online (Tables S1 and S2) . Table 1 shows that across countries there was variation in the frequency of symptoms, diagnoses and antibiotic use. For example, in Paraguay only 25% of patients had a fever, while 55% of the patients from Argentina had a fever. Regarding diagnoses, in Paraguay 50% of the patients were diagnosed with a common cold, while in Uruguay only 30% had that diagnosis. Finally, in Paraguay 24% of patients were prescribed antibiotics, compared with 40% in Bolivia. Figure 1 shows that in all countries patients with diagnoses of viral origin such as common cold, acute bronchitis and influenza were prescribed antibiotics. There was wide variation across countries in the prescribing rate in relation to certain diagnoses. For example, in Bolivia 94% of patients with acute bronchitis were prescribed antibiotics, compared with 21% in Uruguay.
Across all countries, amoxicillin was the most commonly prescribed antibiotic, although there was variation in the prescribing rates, ranging from 45% in Bolivia to 69% in Uruguay. There was also variation in the second most common choice, namely: co-amoxiclav in Argentina (28%) and Uruguay (22%), penicillin in Bolivia (20%) and macrolides in Paraguay (20%) (Figure 2) .
In general, 3701 (33%) of the patients were prescribed antibiotics. In comparison with the overall mean and after adjusting for GP and patient characteristics, antibiotic prescribing varied by a factor of 6, ranging from OR ¼ 0.37 (95% CI ¼ 0.21 -0.65) in Uruguay to OR ¼ 2.58 (95% CI¼ 1.66 -4) in Bolivia (Figure 3 ).
Discussion
Main findings
In this prospective observational study about the use of antibiotics in patients with suspected RTI in general practice across four South Cordoba et al.
American countries, variation across countries was found regarding prescription and selection of antibiotics. Variation in use of antibiotics was not explained by different patient populations.
Comparison with other studies
The present study is the first to describe variation and use of antibiotics in patients with suspected RTI in the South American context (to our knowledge). We found that variation across countries regarding antibiotic prescribing is as large as the variation reported across European countries and is not explained by different patient populations. 11 This finding confirms the importance of combining quantitative and qualitative methodologies in order to understand contextual factors, which can hinder the effectiveness of a cross-national intervention.
South American GPs face similar challenges as their North American and European counterparts regarding the great uncertainty about the viral or bacterial origin of symptoms. 9, 29, 30 This is reflected in the inappropriate prescribing of antibiotics in diagnoses of viral origin and the large differences in prescription rates for certain diagnoses such as acute bronchitis or COPD/chronic bronchitis exacerbations.
GPs prescribed antibiotics in a third of the consultations as in a Dutch study from 2005. 31 Nonetheless, that patient population is not comparable, as in our study twice as many patients had the diagnosis of a common cold. This means that the low level of antibiotic prescribing in our study was caused by a large number of consultations due to a common cold-where in most of the cases GPs decided not to give antibiotics, while in Holland it was caused by more judicious prescribing of antibiotics for other RTIs. 
Comparison of antibiotic prescriptions among four South American countries
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Strengths and weaknesses
The results are based on data from 171 GPs and 11 446 patients across four countries in South America. The large sample size allowed an accurate comparison across contexts.
Furthermore, the prospective design yielded a realistic snapshot of everyday practice in which an easy-to-complete questionnaire was used during the consultation; thus, GPs had no time to think twice about their prescribing practice, thereby minimizing the risk of observation bias.
On the other hand, the interpretation of our results has some limitations. Most of the potential diagnoses share many symptoms and clinical characteristics. Thus, misclassification bias could have had an impact on the distribution of prescribing and choice of antibiotics.
The diagnostic misclassification may be caused by two common factors across the four countries. Firstly, the lack of availability of a point-of-care test, such as a Strep-A test and C-reactive protein (CRP), to help GPs to assess the probability of the bacterial origin of symptoms, or pulse oximetry to assess the severity of symptoms in patients with suspected COPD exacerbation.
Secondly, the absence of guidelines for the management of the most common RTIs in primary care could explain the lack of systematic criteria to make a diagnosis and decide about prescription of antibiotics. For example, in Uruguay and Bolivia GPs do not have guidelines. In Paraguay there are only guidelines for the management of pneumonia in children, and in Argentina there are different guidelines not specifically targeted and written by GPs.
Due to the lack of standardized procedures for the diagnostic process, during the face and content validity of the questionnaire 30 COPD and chronic bronchitis exacerbation were merged into a single item as we could not be completely sure that GPs would only include patients with a confirmed COPD (i.e. spirometric diagnosis).
GPs voluntarily agreed to participate in the study. There are studies reporting that GPs participating in research or qualityimprovement studies tend to have a more conservative prescribing pattern compared with those not participating. 32, 33 This could mean that our sample of GPs is not representative of the GP population of each country.
Finally, we did not have information about comorbidities, smoking status and socioeconomic characteristics of the patients, which could explain some of the use of antibiotics. The questionnaire was face and content validated by the group of Argentinian GPs that participated in the first HAPPY AUDIT study in 2008, 30 though due to the Audit Project Odense methodology these variables could not be included in the questionnaire. However, the effect of these variables on the decision of whether or not to prescribe antibiotics is further analysed in a qualitative article under preparation.
Implications
This first descriptive and explorative study on the use of antibiotics in South America establishes the basis for further research and quality improvement actions in order to reduce inappropriate use of antibiotics.
There is still insufficient information to fully explain the reasons and consequences of the tendency across all these four countries not to use narrow-spectrum antibiotics. Two studies have shown a 15% 6 and 30% 7 decrease in the susceptibility to penicillin of Streptococcus pneumoniae isolated from patients with a community-acquired RTI within the South American context; thus, further research is needed to compare the effect on clinical and microbiological resolution in patients receiving the widely prescribed antibiotics amoxicillin and co-amoxiclav in comparison with patients receiving narrow-spectrum antibiotics.
Both patients and GPs need education. Patients should understand the natural history of RTIs and need education to decide when it is necessary to seek healthcare as well as to understand the effect and side effects of antibiotics.
GPs need better support from the health system concerning the appropriate use of antibiotics. This includes development of The model for the adjusted odds (filled circles) includes the above-mentioned variables plus basic demographics at the GP and patient levels (gender and age) plus confounders that were significant at the 5% level: (i) number of days with symptoms, (ii) signs and symptoms, (iii) diagnosis, and (iv) request for antibiotics and type of practice (see Table S3 ). Cordoba et al.
evidence-based guidelines, access to postgraduate training and better availability of diagnostic tools.
Conclusions
There is variation in overall prescribing and choice of antibiotics, as well as variation in the use of antibiotics across diagnoses. This variation is not explained by GP and patient characteristics. It could be explained by differences in contextual factors external to clinical practice, and uncertainties leading to misdiagnosis. Reducing the inappropriate use of antibiotics and heterogeneity across countries requires greater support from the health systems to provide GPs with evidence-based guidelines and tools (i.e. point-of-care test, postgraduate education) to apply them, as well as facilitating education of patients about the natural course of RTIs and the effect of antibiotics.
